Skip to main content

Table 4 Grade 3 and 4 Adverse Events in 42 patients

From: Adoptive immunotherapy with MUC1-mRNA transfected dendritic cells and cytotoxic lymphocytes plus gemcitabine for unresectable pancreatic cancer

Adverse event

Number of patients

%

Leukocytes

11

26.2

Neutrophils

13

31

Platelets

1

2.4

Hemoglobin

5

11.9

AST

1

2.4

ALT

1

2.4

Fatigue

5

11.9

Anorexia

6

14.3

Diarrhea

3

7.1

Mucositis/stomatitis

1

2.4

Nausea

3

7.1

Vomiting

1

2.4

  1. AST; aspartate aminotransferase, ALT; alanine aminotransferase.